IVERIC bio, Inc.

Fujitsu, Nagoya University, JAMSTEC and NICT develop technology to automatically optimize parameters for solar energetic particle simulations

Two-time Emmy® Award-Winning Actor, Eric Stonestreet, Partners with Iveric Bio to Raise Awareness of Geographic Atrophy (GA)

Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy

European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy

Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy

Deep Track Capital, LP Acquires New Stake in Terns Pharmaceuticals Inc

Astellas Completes Acquisition of Iveric Bio

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ISEE, MDWT, RXDX, UNVR

Iveric Bio stock surges on Astellas Pharma takeover deal

Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma

Iveric Bio Stock Surges. It's Being Bought by Astellas for $5.9 Billion.

Japan's Astellas Pharma to buy Iveric Bio in deal worth $5.9 billion

These Are the Top 10 Holdings of David Kim

Why Is Iveric Bio (ISEE) Stock Up 25% Today?

IVERIC bio, Inc. (ISEE) Q3 2022 Earnings Call Transcript

Iveric Bio to Present at Upcoming Investor Conferences

Apellis Pharma Crashes On Unexpected Delay For Eye Drug — A Boon For Iveric Bio

Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results

These Were The Five Best And Worst Performing Mid-Cap Stocks In September 2022

Iveric Bio to Present Top-line Results for Avacincaptad Pegol from Phase 3 GATHER2 Clinical Trial in Geographic Atrophy at AAO 2022 Annual Meeting